Female patients with lung adenocarcinoma that has pregnancy-specific glycoprotein expression appear to have worse survival outcomes, according to research presented at American Association for Cancer Research Annual Meeting.Pregnancy-specific glycoproteins (PSGs) regulate immune tolerance during pregnancy and prevent fetal rejection, according to study background.